Publications by authors named "Eran Bram"

Claim this Profile
A
A Genotype-Phenotype Study of High-Resolution Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments.
Dejan B Budimirovic, Annette Schlageter, Stela Filipovic-Sadic, Dragana D Protic, Eran Bram

Brain Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, long-read PCR assay.
Eran Bram, Kamyab Javanmardi, Kimberly Nicholson, Kristen Culp, Julie R Thibert

Amyotroph Lateral Scler Frontotemporal Degener· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically programmable pathogen sense and destroy.
Saurabh Gupta, Eran E Bram, Ron Weiss

ACS Synth Biol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.
Michal Stark, Eran E Bram, Martin Akerman, Yael Mandel-Gutfreund, Yehuda G Assaraf

J Biol Chem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin.
Giovanni Luca Beretta, Valentina Benedetti, Giacomo Cossa, Yehuda G A Assaraf, Eran Bram

Biochem Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
Eran E Bram, Michal Stark, Shachar Raz, Yehuda G Assaraf

Neoplasia· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural determinants of imidazoacridinones facilitating antitumor activity are crucial for substrate recognition by ABCG2.
Eran E Bram, Yamit Adar, Nufar Mesika, Michal Sabisz, Andrzej Skladanowski

Mol Pharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells.
Nitzan Gonen, Eran E Bram, Yehuda G Assaraf

Biochem Biophys Res Commun· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
Eran E Bram, Ilan Ifergan, Michal Grimberg, Krzysztof Lemke, Andrzej Skladanowski

Biochem Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates.
Eran Bram, Ilan Ifergan, Assaf Shafran, Bluma Berman, Gerrit Jansen

Cancer Chemother Pharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.
Assaf Shafran, Ilan Ifergan, Eran Bram, Gerrit Jansen, Ietje Kathmann

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis